Cost-Effectiveness Analysis Of Ceftriaxone-Gentamicin And Ampicillin-Gentamicin In Pediatric Pneumonia At Hospital X Madiun
DOI:
https://doi.org/10.30994/jqph.v7i1.465Keywords:
Ampicillin - Gentamicin, Cost Effectiveness, Ceftriaxone-GentamicinAbstract
Pneumonia is an infectious disease caused by bacteria characterized by fever, chills, coughing up phlegm, and breathing difficulty. Generally pneumonia is caused by an infection of Streptococcus pneumoniae bacteria. Antibiotics is a therapy used in pediatric pneumonia patients at hospitals X. in Madiun. This study aims to determine a more cost-effective antibiotics therapy combination between ceftriaxone-Gentamicin and Ampicillin-Gentamicin in pediatric pneumonia patients at Hospital X in Madiun in 2019-2021. This study used a cross sectional design and data collection was carried out retrospectively. There were 39 patients as samples who were pediatric patients aged ≤ 12 years who were adjusted to the inclusion criteria. The datawere identified using decision trees and analyzed cost-effectiveness with ACER and ICER calculations. The ACER value of Ceftriaxone-Gentamicin antibiotic therapy is IDR 6,047,334.23, which is lower than Ampicillin-Gentamicin therapy whch is of IDR 9,730,746.21, thus showing that Seftriaxone-Gentamicin is more cost-effective than Ampicillin-Gentamicin. The ICER calculation has negative result of Idr 500,953.74 so it shows that the Ceftriaxone-Gentamicin combination antibiotic is more cost-effective.
References
Admaja, W., Herowati, R., & Andayani, T. M. (2019). Analisis efektivitas biaya terapi penggunan antibiotk profilaksis cefazoline dan amoxicillin Pada Kasus Bedah sesar. Jurnal Wiyata, 6(1), 40–53.
Aisyah, B. W. (2015). Pemanfaatan Pelayanan Kesehatan Masyarakat Indonesia Analisa Data Susenas-Modul Kesehatan Dan Perumahan Triwulan Iv Tahun 2013 Utilization of Community Health Services Indonesia Susenas Data Analysis-Module of Health and Housing, Fourth Quarter 2013. Jurnal Kebijakan Kesehatan Indonesia, 04(2), 73.
Barbut, F. (2002). Managing antibiotic associated diarrhoea. Bmj, 324(7350), 1345–1346. https://doi.org/10.1136/bmj.324.7350.1345
Fair, R. J., & Tor, Y. (2014). Antibiotics and bacterial resistance in the 21st century. Perspectives in Medicinal Chemistry, 6, 25–64. https://doi.org/10.4137/PMC.S14459
Nadiyah, H., Subirman, & S, D. L. (2017). faktor-faktor yang berhubungan dengan kepesertaan BPJS. Jurnal Kesehatan Masyarakat (e-Journal), 5(3), 2356–3346.
Nalang, A., Citraningtyas, G., & Lolo, W. A. (2018). Analisis Efektivitas Biaya ( Cost Effectiveness Analysis ) Pengobatan Pneumonia Menggunakan Antibiotik. Jurnal Ilmiah Farmasi, 7(3), 321–329.
Setyoningrum, R. A., & Mustiko, H. (2020). Faktor Resiko Kejadian Pneumonia Sangat Berat Pada Anak. Respirologi Indonesia, 40(4), 243–250.
Sumiyati. (2015). Hubungan Jenis Kelamin dan Status Imunisasi DPT dengan Pneumonia pada Bayi Usia 0-12 Bulan. Jurnal Kesehatan Metro Sai Wawai, 8(2), 63–69. https://ejurnal.poltekkes-tjk.ac.id/index.php/JKM/article/view/181/172
Williams, R. (2016). Patient safety. Nursing Management, 23(1), 19. https://doi.org/10.7748/nm.23.1.19.s20
